These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 305882)

  • 21. Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: involvement of endothelium-derived relaxing factor.
    Humphries RG; Tomlinson W; O'Connor SE; Leff P
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):292-7. PubMed ID: 1697386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 6-[p-(4-phenylacetylpiperazin-1-yl)phenyl]-4,5-dihydro-3(2H)pyridazinone (CCI 17810) and aspirin on platelet aggregation and adhesiveness.
    Griffett EM; Kinnon SM; Kumar A; Lecker D; Smith GM; Tomich EG
    Br J Pharmacol; 1981 Apr; 72(4):697-705. PubMed ID: 7284687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of organotins on rat platelet aggregation mechanisms.
    Knowles CO; Johnson TL
    Environ Res; 1986 Feb; 39(1):172-9. PubMed ID: 3943507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of membrane stabilizing activity from honey. An in-vitro approach.
    Manukumar HM; Umesha S
    Acta Sci Pol Technol Aliment; 2015; 14(1):85-90. PubMed ID: 28068024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a new non-steroidal anti-inflammatory agent, sulindac, on platelet function.
    Green D; Given KM; Ts'ao C; Whipple JP; Rossi EC
    Thromb Res; 1977 Feb; 10(2):283-9. PubMed ID: 322358
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.
    Akagi Y; Nio Y; Shimada S; Aoyama T
    Biol Pharm Bull; 2011; 34(2):233-7. PubMed ID: 21415533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase.
    Gaut ZN; Baruth H; Randall LO; Ashley C; Paulsrud JR
    Prostaglandins; 1975 Jul; 10(1):59-66. PubMed ID: 807954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meseclazone, 5-chlorosalicylic acid and acetylsalicylic acid. Comparison of their effects on in vitro and ex vivo platelet aggregation.
    Diamantis W; Kohlhepp WC; Haertlein B; Melton J; Sofia RD
    Thromb Haemost; 1978 Aug; 40(1):24-36. PubMed ID: 103240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
    Han BH; Suh DY; Yang HO; Park YH; Kang YH; Kim YC
    Arzneimittelforschung; 1994 Oct; 44(10):1122-6. PubMed ID: 7818584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual effects of prostaglandins on heat denaturation of serum albumin.
    Grant NH; Alburn HE
    Biochem Pharmacol; 1971 Feb; 20(2):429-36. PubMed ID: 5170127
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of 2-(4-(2-imidazo[1,2-a]pyridyl)phenyl) propionic acid (Y-9213) and anti-inflammatory drugs on erythrocytes, polymorphonuclear leukocytes and lysosomes in vitro.
    Goto K; Hisadome M; Maruyama Y; Imamura H
    Jpn J Pharmacol; 1978 Jun; 28(3):433-46. PubMed ID: 702946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
    Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
    Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of piroxicam on platelet aggregation.
    Gaynor BJ; Constantine JW
    Experientia; 1979 Jun; 35(6):797-8. PubMed ID: 467595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):263-79. PubMed ID: 1180617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of anti-inflammatory drugs on platelet aggregation in rabbits.
    Takano S; Aikawa T; Oishi T; Goto M; Tamura O; Suzuki T
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):501-14. PubMed ID: 451335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.